Relationship between fatty liver and glucose metabolism: A cross-sectional study in 571 obese children

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 2, 2012, Pages 120-126

  Bedogni, G ^a,b   Gastaldelli, A ^c   Manco, M ^d   De Col, A ^e   Agosti, F ^e   Tiribelli, C ^a   Sartorio, A ^e  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CNR   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Children; Impaired glucose tolerance; Insulin resistance; Non alcoholic fatty liver disease; Obesity; Oral glucose tolerance test; Type 2 diabetes mellitus

Indexed keywords

INSULIN;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BLOOD; BODY MASS; CHILD; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; LIVER; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY;

ADOLESCENT; AREA UNDER CURVE; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIVER; MALE; OBESITY;

EID: 84856621545     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.05.003     Document Type: Article

References (30)

1. Burns N., Finucane F.M., Hatunic M., Gilman M., Murphy M., Gasparro D., et al. Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia 2007, 50:1500-1508.
2. Moscatiello S., Manini R., Marchesini G. Diabetes and liver disease: an ominous association. Nutr Metab Cardiovasc Dis 2007, 17:63-70.
3. Dunn W., Schwimmer J.B. The obesity epidemic and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep 2008, 10:67-72.
4. Gastaldelli A., Kozakova M., Højlund K., Flyvbjerg A., Favuzzi A., Mitrakou A., et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009, 49:1537-1544.
5. Loria P., Lonardo A., Bellentani S., Day C.P., Marchesini G., Carulli N. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. Nutr Metab Cardiovasc Dis 2007, 17:684-698.
6. Targher G., Marra F., Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?. Diabetologia 2008, 51:1947-1953.
7. Manco M., Bottazzo G., DeVito R., Marcellini M., Mingrone G., Nobili V. Nonalcoholic fatty liver disease in children. J Am Coll Nutr 2008, 27:667-676.
8. Gastaldelli A., Ferrannini E., Miyazaki Y., Matsuda M., DeFronzo R.A. San Antonio metabolism study. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 2004, 47:31-39.
9. Gastaldelli A., Miyazaki Y., Pettiti M., Buzzigoli E., Mahankali S., Ferrannini E., et al. Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J Clin Endocrinol Metab 2004, 89:3914-3921.
10. DeFronzo R.A. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009, 58:773-795.
11. Cali A.M., De Oliveira A.M., Kim H., Chen S., Reyes-Magical M., Escalera S., et al. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?. Hepatology 2009, 49:1896-1903.
12. Yeckel C.W., Taksali S.E., Dziura J., Weiss R., Burgert T.S., Sherwin R.S., et al. The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance. J Clin Endocrinol Metab 2005, 90:747-754.
13. Gastaldelli A., Cusi K., Pettiti M., Hardies J., Miyazaki Y., Berria R., et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 2007, 133:496-506.
14. Tanner J.M., Whitehouse R.H. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976, 51:170-179.
15. Lohman T.G., Roche A.F., Martorell R. Anthropometric standardization reference manual 1988, Human Kinetics Books, Champaign, IL.
16. Cacciari E., Milani S., Balsamo A., Spada E., Bona G., Cavallo L., et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 2006, 29:581-593.
17. Bedogni G., Miglioli L., Masutti F., Tiribelli C., Marchesini G., Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005, 42:44-52.
18. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation 2006, World Health Organization (WHO) and International Diabetes Federation (IDF), Geneva.
19. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
20. Katz A., Nimbi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
21. Sartorio A., Del Col A., Agosti F., Mazzilli G., Bellentani S., Tiribelli C., et al. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr 2007, 61:877-883.
22. Saverymuttu S.H., Joseph A.E., Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986, 292:13-15.
23. Ryan T.P. Modern regression methods 2009, Wiley, New York.
24. Gould Quantile regression with bootstrapped standard errors. STATA J 1992, 19-21.
25. Royston P., Altman D.G., Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006, 25:127-141.
26. Vittinghoff E., Glidden D., Shiboski S.C., McCulloch C.E. Regression methods in biostatistics: linear, logistic, survival, and repeated measures models 2005, Springer, New York.
27. Bloomgarden Z.T. Type 2 diabetes in the young: the evolving epidemic. Diabetes Care 2004, 27:998-1010.
28. Fabbrini E., Sullivan S., Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010, 51:679-689.
29. Manco M., Bedogni G., Monti L., Morino G., Natali G., Nobili V. Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. Atherosclerosis 2010, 209:463-468.
30. Manco M., Bedogni G., Marcellini M., Devito R., Ciampalini P., Sartorelli M.R., et al. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut 2008, 57:1283-1287.